Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin

Cellular and Molecular Life Sciences

Volumn 71, Issue 22, 2014, Pages 4457-4470

  Shteingauz, Anna ^a   Ilan, Neta ^a   Vlodavsky, Israel ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cytoplasmic tail; Heparanase; Processing; Syndecan; Uptake

Indexed keywords

ALPHA ACTININ; HEPARANASE; SYNDECAN 1; SYNTENIN; ACTININ; BETA GLUCURONIDASE; SMALL INTERFERING RNA;

ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETICS; HEK293 CELL LINE; METABOLISM; MOUSE; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; TUMOR CELL LINE;

ACTININ; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; GLUCURONIDASE; HEK293 CELLS; HUMANS; MICE; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNDECAN-1; SYNTENINS;

EID: 84925286076     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1629-9     Document Type: Article

References (48)

1. Dempsey LA, Brunn GJ, Platt JL (2000) Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25:349-351
2. Parish CR, Freeman C, Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99-M108
3. Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108(3):341-347
4. Gingis-Velitski S, Zetser A, Kaplan V, Ben-Zaken O, Cohen E, Levy-Adam F, Bashenko Y, Flugelman MY, Vlodavsky I, Ilan N (2004) Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem 279:44084-44092
5. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N (2004) Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279:23536-23541
6. Nadav L, Eldor A, Yacoby-Zeevi O, Zamir E, Pecker I, Ilan N, Geiger B, Vlodavsky I, Katz BZ (2002) Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 115:2179-2187
7. Vreys V, Delande N, Zhang Z, Coomans C, Roebroek A, Durr J, David G (2005) Cellular uptake of mammalian heparanase precursor involves low-density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. J Biol Chem 280:33141-33148
8. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N (2004) Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117:2249-2258
9. Levy-Adam F, Abboud-Jarrous G, Guerrini M, Beccati D, Vlodavsky I, Ilan N (2005) Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase. J Biol Chem 280:20457-20466
10. Goldshmidt O, Nadav L, Aingorn H, Irit C, Feinstein N, Ilan N, Zamir E, Geiger B, Vlodavsky I, Katz BZ (2002) Human heparanase is localized within lysosomes in a stable form. Exp Cell Res 281:50-62
11. Cohen E, Atzmon R, Vlodavsky I, Ilan N (2005) Heparanase processing by lysosomal/endosomal protein preparation. FEBS Lett 579:2334-2338
12. Abboud-Jarrous G, Atzmon R, Peretz T, Palermo C, Gadea BB, Joyce JA, Vlodavsky I (2008) Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem 283:18167-18176
13. Abboud-Jarrous G, Rangini-Guetta Z, Aingorn H, Atzmon R, Elgavish S, Peretz T, Vlodavsky I (2005) Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J Biol Chem 280:13568-13575
14. Arvatz G, Shafat I, Levy-Adam F, Ilan N, Vlodavsky I (2011) The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer Metastasis Rev 30:253-268
15. Levy-Adam F, Feld S, Cohen-Kaplan V, Shteingauz A, Gross M, Arvatz G, Naroditsky I, Ilan N, Doweck I, Vlodavsky I (2010) Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. J Biol Chem 285:28010-28019
16. Fux L, Ilan N, Sanderson RD, Vlodavsky I (2009) Heparanase: busy at the cell surface. Trends Biochem Sci 34:511-519
17. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, Iozzo RV, Swenson TL, Fisher EA, Williams KJ (1997) The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invst 100:1611-1622
18. Fuki IV, Meyer ME, Williams KJ (2000) Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochem J 351:607-612
19. Ohkawara B, Glinka A, Niehrs C (2011) Rspo3 binds syndecan 4 and induces Wnt/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis. Dev Cell 20:303-314
20. Ben-Zaken O, Gingis-Velitski S, Vlodavsky I, Ilan N (2007) Heparanase induces Akt phosphorylation via a lipid raft receptor. Biochem Biophys Res Commun 361:829-834
21. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ (1985) Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1:1-39
22. Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Intl J Biochem Cell Biol 38:2018-2039
23. Chen K, Williams KJ (2013) Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor. J Biol Chem 288:13988-13999
24. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66:1455-1463
25. Levy-Adam F, Feld S, Suss-Toby E, Vlodavsky I, Ilan N (2008) Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans. PLoS One 3:e2319
26. Cohen-Kaplan V, Doweck I, Naroditsky I, Vlodavsky I, Ilan N (2008) Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res 68:10077-10085
27. Cohen-Kaplan V, Jrbashyan J, Yanir Y, Naroditsky I, Ben-Izhak O, Ilan N, Doweck I, Vlodavsky I (2012) Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer. J Biol Chem 287:6668-6678
28. Vlodavsky I (2001) Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. Curr Protoc Cell Biol. doi: 10.1002/0471143030.cb1004s01 (chap 10, unit 10.4)
29. Beauvais DM, Rapraeger AC (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2:3
30. Tkachenko E, Rhodes JM, Simons M (2005) Syndecans: new kids on the signaling block. Circulation Res 96:488-500
31. McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M (2000) Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun 276:1170-1177
32. Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A (2011) Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet 80:305-318
33. Zerial M, McBride H (2001) Rab proteins as membrane organizers. Nature Rev Mol Cell Biol 2:107-117
34. Stenmark H (2009) Rab GTPase as coordinators of vesicle traffic. Nature Rev Mol Cell Biol 10:513-525
35. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M (1999) Functions of cell surface heparan sulfate proteoglycans. An Rev Biochem 68:729-777
36. Capila I, Linhardt RJ (2002) Heparin-protein interactions. Angew Chem Int Ed Engl 41:391-412
37. Cardin AD, Weintraub HJ (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32
38. Zhang L (2010) Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins. Prog Mol Biol Transl Sci 93:1-17
39. Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5:526-542
40. Multhaupt HA, Yoneda A, Whiteford JR, Oh ES, Lee W, Couchman JR (2009) Syndecan signaling: when, where and why? J Physiol Pharmacol 60:31-38
41. Zimmermann P, David G (1999) The syndecans, tuners of transmembrane signaling. Faseb J 13(Suppl):S91-S100
42. Roghani M, Moscatelli D (1992) Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267:22156-22162
43. Vlodavsky I, Beckhove P, Lerner I, Pisano C, Meirovitz A, Ilan N, Elkin M (2012) Significance of heparanase in cancer and inflammation. Cancer Microenviron 5:115-132
44. Vreys V, David G (2007) Mammalian heparanase: what is the message? J Cell Mol Med 11:427-452
45. Ding Q, Wang Z, Chen Y (2009) Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway. Cell Res 19:317-327
46. Beekman JM, Coffer PJ (2008) The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J Cell Sci 121:1349-1355
47. Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, Coomans C, Schulz J, N'Kuli F, Courtoy PJ, David G (2005) Syndecan recycling is controlled by syntenin-PIP2 interaction and Arf6. Dev Cell 9:377-388
48. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB (2005) mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res 65:10901-10911